Roivant Sciences ROIV Cash Flow Statement (2020-2026)

NASDAQ ROIV
$34.92 +0.22 (+0.63%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Roivant Sciences Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Roivant Sciences reported cash from operations of -$270.50M and free cash flow of -$270.92M for the quarter ended Jun 2026, down 32.4% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-225.64M-306.09M-291.31M-353.78M-315.92M-384.90M-15.46M-327.85M-331.12M5,072.67M-64.78M57.49M-279.92M169.38M-252.38M-273.91M-166.04M-313.70M355.74M-290.61M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
1.37M1.71M2.68M5.08M5.15M5.95M5.84M5.59M5.39M5.23M4.88M4.84M2.92M1.43M1.10M0.92M0.69M0.64M0.60M
Share-based CompensationStock Comp.
397.31M71.22M77.16M72.79M61.98M57.73M25.28M49.26M49.32M54.33M46.72M50.19M71.67M83.68M83.49M82.18M81.82M105.00M77.17M83.34M
Gains from Equity InvestmentsGains Equity
Gains from Sales and DivestituresGains Divest
5,348.41M110.39M
Gains from Investment SecuritiesGains Investment
452.37M-38.04M-24.55M-54.68M25.95M32.46M-7.56M-45.85M-10.47M15.91M15.23M48.38M-21.31M12.90M-19.13M128.50M21.59M-25.92M36.64M
Other non-cash itemsOther Non-Cash
13.15M23.02M-39.26M50.49M-13.54M62.36M-24.04M50.46M21.53M9.33M36.72M-110.93M-2.27M27.35M-7.83M15.31M14.15M22.09M2.91M8.67M
Change in Working Capital
Change in Account PayablesChange Payables
62.85M-52.82M11.71M-19.45M26.23M7.20M-9.61M11.94M-1.80M-8.35M20.89M-25.27M7.21M0.05M-0.17M-11.75M3.00M-3.99M16.16M7.11M
Change in Accured ExpensesChange Accured Exp.
25.91M17.01M15.02M-18.18M19.62M4.26M33.25M-49.96M37.57M-3.40M55.94M-37.58M21.11M-3.03M9.44M-25.00M12.52M8.58M63.23M-13.91M
Change in TaxesChange Taxes
-3.00M-10.18M
Change in Other Operating AssetsOther Assets Change
11.94M11.32M18.90M0.82M18.05M4.64M21.64M-7.51M46.22M16.33M-4.13M41.72M-20.09M2.81M1.45M2.73M-11.04M21.97M
Change in Other Operating LiabilitiesOther Liabilities Change
0.03M-52.11M-0.69M-2.30M-2.45M-2.06M0.36M-2.01M-2.15M-2.00M-4.56M-1.82M-1.63M-2.02M0.53M5.39M-6.71M-0.79M-1.28M7.64M
Other Working Capital ChangesOther WC Changes
3.28M1.99M23.47M3.13M6.04M-5.83M-0.04M9.43M5.14M27.42M-50.79M12.27M-20.51M-6.40M20.63M-0.07M-3.21M8.30M9.76M-14.32M
Cash from OperationsCash from Ops.
-120.60M-268.49M-147.47M-252.08M-189.63M-222.59M-179.09M-249.93M-196.43M-210.45M-108.46M-192.83M-266.81M-207.25M-172.57M-204.38M-185.66M-196.48M-163.82M-270.50M
Investing Activities
Capital ExpendituresCapex
2.76M6.07M6.26M7.46M3.10M0.51M1.62M0.40M0.28M0.36M0.35M0.97M1.00M1.83M0.81M4.04M7.85M-4.94M1.26M0.42M
Change in Property, Plant and EquipmentChange in PP&E
-2.76M-6.07M-6.26M-7.46M-3.10M-0.51M-1.62M-0.40M-0.28M-0.36M-0.35M-0.97M-1.00M-1.83M-0.81M-4.04M-7.85M4.94M-1.26M-0.42M
Divestments
75.20M75.00M
Net of Acquisitions & DivestmentsNet Acquisitions
75.20M75.00M
Purchase of InvestmentsInvestments Purchased
3,402.99M658.54M1,801.68M976.73M1,013.71M286.51M
Sale and Maturity of InvestmentsInvestments Sold
960.00M1,000.00M720.00M1,105.00M1,120.77M568.19M
Other Investing ActivitiesOther investing
0.56M-3.62M-3.00M0.61M0.51M-83.68M7.28M-31.15M0.01M-4.42M
Cash from Investing ActivitiesCash from Investing
317.41M-6.07M-5.70M-7.46M-146.85M-3.51M113.55M0.11M-36.45M5,233.04M6.93M-0.97M-3,293.59M454.07M1,074.19M-1,085.72M120.42M109.47M173.49M281.26M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
7.34M7.34M7.42M8.04M7.81M7.57M7.66M7.67M1.83M1.83M49.09M
Non-Current Debt
-7.34M-7.34M-7.42M-8.04M-7.81M-7.57M-7.66M-7.67M-1.83M-1.83M-49.09M
Current Debt
159.90M
Net Debt Issuances and RepaymentsNet Debt Issuance
152.56M-7.34M-7.42M-8.04M-7.81M-7.57M-7.66M-7.67M-1.83M-1.83M-49.09M
Change in Capital Stock
Common Stock IssuedStock Issued
313.42M0.41M95.30M219.81M21.03M221.53M8.88M3.66M2.27M7.27M28.12M12.97M30.06M69.07M119.20M51.19M76.65M
Shares Repurchased
2.25M8.33M-8.33M648.39M106.05M243.35M295.45M208.29M111.21M206.73M
Net Shares Issued and RepurchasedNet Shares Issued
311.18M0.41M-8.33M8.33M95.30M219.81M21.03M221.53M8.88M3.66M-646.11M-98.79M-215.23M-282.47M-178.24M69.07M119.20M-60.03M-130.08M
Net Equity Issued and RepurchasedNet Equity Issued
311.18M0.41M-8.33M8.33M95.30M219.81M21.03M221.53M8.88M3.66M-646.11M-98.79M-215.23M-282.47M-178.24M69.07M119.20M-60.03M-130.08M
Cash from Financing ActivitiesCash from Financing
303.93M-8.42M1.07M141.98M-7.34M154.50M210.33M7.48M207.87M236.64M-32.62M-660.62M-109.07M-272.95M-177.15M-187.77M62.59M328.19M-68.78M-181.51M
Additional items
Exchange Rate EffectFX Effect
6.28M-0.12M-1.45M3.04M-0.86M-2.74M5.04M-1.07M-0.49M0.82M1.21M0.43M1.32M0.32M
Change in Cash
500.75M-282.99M-152.10M-117.57M-343.82M-71.61M151.08M-242.47M-26.46M5,262.27M-135.01M-857.15M-3,664.43M-27.20M723.99M-1,477.05M-1.45M241.61M-57.79M-170.44M
Ending Cash Balance
2,509.12M2,226.14M2,074.03M1,956.47M1,692.12M1,423.19M6,685.46M6,550.45M5,693.30M2,028.87M2,001.67M2,725.66M1,248.61M1,247.16M1,488.77M1,430.98M1,260.54M
Free Cash FlowFCF
-123.36M-274.57M-153.73M-259.54M-192.73M-223.10M-180.71M-250.34M-196.70M-210.81M-108.81M-193.79M-267.80M-209.08M-173.38M-208.42M-193.51M-191.55M-165.08M-270.92M
Net Cash FlowNCF
500.75M-282.99M-152.10M-117.57M-343.82M-71.61M144.80M-242.35M-25.01M5,259.23M-134.15M-854.41M-3,669.47M-26.13M724.48M-1,477.87M-2.66M241.18M-59.10M-170.75M

Roivant Sciences Cash Flow Statement API

Pull Roivant Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ROIV&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY